Of note, HSCT-MSC showed a trend towards a greater residual proliferation in comparison to the other study groups, but this difference was not statistically significant (B-MSC 25.84% [IQR 16.82–39.30], GT-MSC 25.84% [IQR 16.82–39.30], and HSCT-MSC 42.23 [20.54–53.13], p = 0.13) ( Figure 3D ).
← all excerpts
Role of the mesenchymal stromal cells in bone marrow failure of Fanconi Anemia patients.
1
—
—